Financials

Discussions Technicals Seasonals

RDG fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Read-Gene SA engages in the medical research and testing. It develops cancer prevention treatment based on genetic tests. The company was founded on September 27, 2005 and is headquartered in Dobra, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

RDG has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company